CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding CymaBay Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 100 | 1 | 118 | +19 |
| Shares | 62.3M | 1.64M | 65.3M | +4.64M (+7.7%) |
| Value | $217.9M | $5.75M | $404.2M | +$192.1M (+90.5%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (7)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 596,300 | $2.09M |
| Group One Trading, L.P. | 18,932 | $66.0K |
| Verition Fund Management LLC | 15,800 | $55.0K |
| Bank of Nova Scotia | 14,286 | $50.0K |
| Dynamic Technology Lab Private Ltd | 10,094 | $35.0K |
| Massmutual Trust Co FSB | 288 | $1.00K |
| Parallel Advisors, LLC | 1 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $5.75M |